However, it doesnt work in the same way as approved weight loss treatments like glucagon-like peptide-1 agonists (or GLP-1 injections)
Once the necessary information is received, Blue Cross Blue Shield will then review the request for authorization
However, due to the cost of these medications as well as potential side effects, taking these drugs for the rest of your life may not be a viable option
Cagrilintide + Tirzepatide vs CagriSema vs Cagrilintide + Retatrutide The two most common alternatives are CagriSema (the evidence-backed combination of cagrilintide + semaglutide) and cagrilintide + retatrutide (a broader but more speculative option)
Patients were matched to account for demographics, comorbidities and cancer risk factors
On Monday, February 24, 2025, OFA filed a lawsuit against FDA in Fort Worth Texas over FDAs decision to remove semaglutide from the drug shortage list